This study shows that CGA could increase the contents of Bifidobacterium and reduced the Escherichia coli in NAFLD mice, suggesting its promoting effect on GLP-1 secretion may be related with its effect on these gut microbiota. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.